Showing results (91-100 of 300) with videos related to

Sort By:
Pageof 30
BMC Gastroenterology|June 14, 2022
Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world studyLingyun Zhang, Jiayu Zhang, Yan Wang, et al.
Oncotargets and Therapy|February 23, 2017
Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathwayYuehong Cui, Qian Li, Hong Li, et al.
BMC Cancer|December 21, 2014
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patientsWenhua Li, Jianming Xu, Lin Shen, et al.
Cancer Management and Research|October 29, 2020
Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese PatientsShan Yu, Yan Wang, Xi Cheng, et al.
Clinical Colorectal Cancer|January 4, 2024
Efficacy of Pyrotinib With/Without Trastuzumab in Treatment-Refractory, HER2-Positive Metastatic Colorectal Cancer: Result From a Prospective Observational StudyHaojie Zhou, Minzhi Lv, Wei Li, et al.
Animal Bioscience|June 2, 2026
Dietary protein levels impact growth, meat quality, and muscle protein pathways in growing-finishing pigs under low-temperature conditionsTing Xie, Zhibo Wu, Feng Li, et al.
Oncotargets and Therapy|November 10, 2018
Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimenCheng Tang, Xi Cheng, Shan Yu, et al.
Nature Communications|October 15, 2024
Universal high-efficiency electrocatalytic olefin epoxidation via a surface-confined radical promotionPan Ran, Aoqian Qiu, Tianshu Liu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 6, 2016
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing ChemotherapyZhiming Wang, Li Liang, Yiyi Yu, et al.
Cancer Medicine|May 21, 2026
Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 StudyBei Xu, Guopei Zhu, Jin Lu, et al.
Pageof 30